Our previous studies demonstrated increased blood CD8 T cell function, which we refer to as ‘hyperfunction’, in chronic HCV‐infected individuals with advanced liver fibrosis compared with minimal fibrosis, which persisted long after attaining sustained virologic response (SVR) with direct‐acting antiviral (DAA) therapy [17]. This evidence concerns the gene CD8A and Hepatic fibrosis.